Objectives: Breast-feeding induces a gut microbiota rich in bifidobacteria, whereas formula-fed babies have a more diverse colonization. This ecosystem contributes to the development of the immune response and the lower incidence of diarrhea and allergy in breast-fed infants. This randomized double-blind controlled trial aimed to evaluate the bifidogenic effect of a mainly whey protein study formula low in phosphate and protein, allowing a composition closer to that of human milk.
Patients and Methods: One hundred ninety healthy infants exclusively received study formula with or without Bifidobacterium longum (BL999), or a control formula for up to 4 months. Breast-fed infants served as a reference population. Stool samples collected at 2 months of age were analyzed for bacterial counts (log colony-forming unit [CFU]/g).
Results: Bifidobacteria counts were significantly higher in infants receiving the study formula alone (10.0[0.8], P < 0.0001, median [interquartile range]) or with BL999 (9.8[1.4], P < 0.01) than control (9.2[3.5]), and were similar to breast-fed infants (10.1[0.4], P > 0.05). The difference between the 2 study groups was 0.16 log CFU/g (90% confidence interval [CI] [0–0.4]), within the predefined equivalence margin. Microbiota profile, as a percentage of total bacteria counts, showed about 50% Bifidobacteria, 8% Enterobacteria, and <10% Clostridia in study formulae and breast-fed infants versus 22%, 13%, and 19% in controls, respectively. There were no significant differences in growth measurements, digestive tolerance, and adverse events between groups.
Conclusions: This study showed that infant formula closer resembling human milk was more bifidogenic than the control formula and led to a microbiota profile similar to that for breast-fed infants.
*Neonatology Department, France
†Biology Laboratory, Maternité Régionale Universitaire, Nancy, France
‡Nestlé Research Center, Switzerland
§Nestlé Nutrition, Nestec Ltd, Vevey, Switzerland.
Received 2 November, 2010
Accepted 13 January, 2011
Address correspondence and reprint requests to Prof Jean-Michel Hascoët, Department of Neonatology-Maternité Régionale Universitaire, 10 Rue du Dr Heydenreich, 54042 Nancy, France (e-mail: email@example.com).
This study was sponsored by Nestlé Nutrition, Nestec Ltd (Vevey, Switzerland).
P.G.S. is an employee of Nestlé Nutrition, Nestec Ltd.
The other authors report no conflicts of interest.